Tag Archive for: Preclinical

Reading immune responses: why platform choices matter

, , , ,
We highlight five different ways to measure the “same” immune response and discuss how thoughtful choices in analytical platforms can optimize an immunology pipeline.

Expert Insights: Navigating the Evolving Landscape of Preclinical Oncology

, ,
Dr. Jenny Worthington, Managing Director of Axis Bioservices, discusses the present and future of preclinical oncology, and how to choose the 'right' models to test drugs targeting a disease as complex as cancer.